401 related articles for article (PubMed ID: 32816031)
1. Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease.
Mahtta D; Ramsey DJ; Al Rifai M; Nasir K; Samad Z; Aguilar D; Jneid H; Ballantyne CM; Petersen LA; Virani SS
JAMA Netw Open; 2020 Aug; 3(8):e2011051. PubMed ID: 32816031
[TBL] [Abstract][Full Text] [Related]
2. Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
Lee MT; Mahtta D; Ramsey DJ; Liu J; Misra A; Nasir K; Samad Z; Itchhaporia D; Khan SU; Schofield RS; Ballantyne CM; Petersen LA; Virani SS
JAMA Cardiol; 2021 Jul; 6(7):782-790. PubMed ID: 33881448
[TBL] [Abstract][Full Text] [Related]
3. Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.
Mahtta D; Lee MT; Ramsey DJ; Akeroyd JM; Krittanawong C; Khan SU; Sinh P; Alam M; Garratt KN; Schofield RS; Ballantyne CM; Petersen LA; Virani SS
Cardiovasc Drugs Ther; 2022 Feb; 36(1):93-102. PubMed ID: 33400053
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
[TBL] [Abstract][Full Text] [Related]
5. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
Bellows BK; Olsen CJ; Voelker J; Wander C
J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
[TBL] [Abstract][Full Text] [Related]
6. Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
JAMA Cardiol; 2019 Mar; 4(3):206-213. PubMed ID: 30758506
[TBL] [Abstract][Full Text] [Related]
7. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
[TBL] [Abstract][Full Text] [Related]
8. Trends in Provision of Medications and Lifestyle Counseling in Ambulatory Settings by Gender and Race for Patients With Atherosclerotic Cardiovascular Disease, 2006-2016.
Mufarreh A; Shah AJ; Vaccarino V; Kulshreshtha A
JAMA Netw Open; 2023 Jan; 6(1):e2251156. PubMed ID: 36656581
[TBL] [Abstract][Full Text] [Related]
9. Relation Between Cardiology Follow-Up Visits, Evidence-Based Statin Prescribing, and Statin Adherence (from the Veterans Affairs Health Care System).
Rehman H; Ahmed ST; Akeroyd J; Mahtta D; Jia X; Rifai MA; Nasir K; Jneid H; Khalid MU; Alam M; Toth PP; Virani SS
Am J Cardiol; 2019 Oct; 124(8):1165-1170. PubMed ID: 31405545
[TBL] [Abstract][Full Text] [Related]
10. Association between frequency of primary care provider visits and evidence-based statin prescribing and statin adherence: Findings from the Veterans Affairs system.
Ahmed ST; Mahtta D; Rehman H; Akeroyd J; Al Rifai M; Rodriguez F; Jneid H; Nasir K; Samad Z; Alam M; Petersen LA; Virani SS
Am Heart J; 2020 Mar; 221():9-18. PubMed ID: 31896038
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020.
Jacobs JA; Addo DK; Zheutlin AR; Derington CG; Essien UR; Navar AM; Hernandez I; Lloyd-Jones DM; King JB; Rao S; Herrick JS; Bress AP; Pandey A
JAMA Cardiol; 2023 May; 8(5):443-452. PubMed ID: 36947031
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk.
Lin I; Sung J; Sanchez RJ; Mallya UG; Friedman M; Panaccio M; Koren A; Neumann P; Menzin J
J Manag Care Spec Pharm; 2016 Jun; 22(6):685-98. PubMed ID: 27231796
[TBL] [Abstract][Full Text] [Related]
13. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
[TBL] [Abstract][Full Text] [Related]
14. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
[TBL] [Abstract][Full Text] [Related]
15. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
Vassy JL; Lu B; Ho YL; Galloway A; Raghavan S; Honerlaw J; Tarko L; Russo J; Qazi S; Orkaby AR; Tanukonda V; Djousse L; Gaziano JM; Gagnon DR; Cho K; Wilson PWF
JAMA Netw Open; 2020 Jul; 3(7):e208236. PubMed ID: 32662843
[TBL] [Abstract][Full Text] [Related]
16. Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan.
Chen ST; Huang ST; Shau WY; Lai CL; Li JZ; Fung S; Tse VC; Lai MS
BMC Cardiovasc Disord; 2019 Mar; 19(1):62. PubMed ID: 30876393
[TBL] [Abstract][Full Text] [Related]
17. Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES study.
Anderson JL; Knowlton KU; May HT; Bair TL; Armstrong SO; Lappé DL; Muhlestein JB
J Clin Lipidol; 2018; 12(4):1008-1018.e1. PubMed ID: 29703626
[TBL] [Abstract][Full Text] [Related]
18. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.
Khunti K; Danese MD; Kutikova L; Catterick D; Sorio-Vilela F; Gleeson M; Kondapally Seshasai SR; Brownrigg J; Ray KK
JAMA Netw Open; 2018 Dec; 1(8):e185554. PubMed ID: 30646277
[TBL] [Abstract][Full Text] [Related]
19. High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES study.
May HT; Knowlton KU; Anderson JL; Lappé DL; Bair TL; Muhlestein JB
Eur Heart J Qual Care Clin Outcomes; 2022 May; 8(3):352-360. PubMed ID: 33787865
[TBL] [Abstract][Full Text] [Related]
20. Statin Use in Older Adults with Stable Atherosclerotic Cardiovascular Disease.
Spencer-Bonilla G; Chung S; Sarraju A; Heidenreich P; Palaniappan L; Rodriguez F
J Am Geriatr Soc; 2021 Apr; 69(4):979-985. PubMed ID: 33410499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
